156 related articles for article (PubMed ID: 29332446)
1. Lung Cancer Complicated With Asymptomatic Pulmonary Embolism: Clinical Analysis of 84 Patients.
Li G; Li Y; Ma S
Technol Cancer Res Treat; 2017 Dec; 16(6):1130-1135. PubMed ID: 29332446
[TBL] [Abstract][Full Text] [Related]
2. [Clinical features in 23 lung cancer patients complicated with pulmonary thromboembolism].
Li N; Wang Y
Zhongguo Fei Ai Za Zhi; 2014 Mar; 17(3):254-9. PubMed ID: 24667264
[TBL] [Abstract][Full Text] [Related]
3. [Clinical characteristics of lung cancer complicated with pulmonary embolism].
Sun W; Wang H; Wen Z; Ma N; Xiao Y; Ma L; Wei X; Xie X
Zhonghua Jie He He Hu Xi Za Zhi; 2016 Mar; 39(3):198-202. PubMed ID: 26980534
[TBL] [Abstract][Full Text] [Related]
4. Asymptomatic pulmonary embolism in lung cancer: prevalence and analysis of clinical and radiological characteristics in 141 outpatients.
Tiseo M; Bersanelli M; Pesenti Barili M; Bartolotti M; De Luca G; Gelsomino F; Camisa R; Cademartiri F; Ardizzoni A
Tumori; 2012; 98(5):594-600. PubMed ID: 23235754
[TBL] [Abstract][Full Text] [Related]
5. D-dimer levels correlate with mortality in patients with acute pulmonary embolism: Findings from the RIETE registry.
Grau E; Tenías JM; Soto MJ; Gutierrez MR; Lecumberri R; Pérez JL; Tiberio G;
Crit Care Med; 2007 Aug; 35(8):1937-41. PubMed ID: 17581488
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary tumor embolism: a rare cause of acute right heart failure with elevated D-dimers.
Kridel R; Myit S; Pache JC; Gaspoz JM
J Thorac Oncol; 2008 Dec; 3(12):1482-3. PubMed ID: 19057276
[TBL] [Abstract][Full Text] [Related]
7. The relationship between tumor markers and pulmonary embolism in lung cancer.
Xiong W; Zhao Y; Xu M; Guo J; Pudasaini B; Wu X; Liu J
Oncotarget; 2017 Jun; 8(25):41412-41421. PubMed ID: 28575869
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary tumor embolism.
Shigematsu H; Andou A; Matsuo K
J Thorac Oncol; 2009 Jun; 4(6):777; author reply 777-8. PubMed ID: 19461409
[No Abstract] [Full Text] [Related]
9. [Normal D-dimer concentration in hospitalized patients with lung diseases].
Fijałkowska A; Wiatr E; Kurzyna M; Kuca P; Burakowski J; Kober J; Szturmowicz M; Wawrzyńska L; Roszkowska-Śliż B; Tomkowski W; Roszkowski-Śliż K; Torbicki A
Pneumonol Alergol Pol; 2012; 80(2):101-8. PubMed ID: 22370978
[TBL] [Abstract][Full Text] [Related]
10. Clinical features of pulmonary embolism in patients with lung cancer: A meta-analysis.
Hua X; Han SH; Wei SZ; Wu Y; Sha J; Zhu XL
PLoS One; 2019; 14(9):e0223230. PubMed ID: 31568496
[TBL] [Abstract][Full Text] [Related]
11. [A clinical study on the pathogenesis of lung cancer-related cerebral infarction].
Xie XR; Qin C; Chen L; Cheng DB; Huang JY; Wei XX; Yu LX; Liang ZJ
Zhonghua Nei Ke Za Zhi; 2017 Feb; 56(2):99-103. PubMed ID: 28162178
[No Abstract] [Full Text] [Related]
12. Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial.
Reck M; Kaiser R; Mellemgaard A; Douillard JY; Orlov S; Krzakowski M; von Pawel J; Gottfried M; Bondarenko I; Liao M; Gann CN; Barrueco J; Gaschler-Markefski B; Novello S;
Lancet Oncol; 2014 Feb; 15(2):143-55. PubMed ID: 24411639
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of preoperative monocyte counts in patients with resected lung adenocarcinoma.
Kumagai S; Marumo S; Shoji T; Sakuramoto M; Hirai T; Nishimura T; Arima N; Fukui M; Huang CL
Lung Cancer; 2014 Sep; 85(3):457-64. PubMed ID: 25043641
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of the factors associated with abnormal coagulation and prognosis
in patients with non-small cell lung cancer].
Li Y; Wei S; Wang J; Hong L; Cui L; Wang C
Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):789-96. PubMed ID: 25404269
[TBL] [Abstract][Full Text] [Related]
15. The Preoperative Composite Physiologic Index May Predict Mortality in Lung Cancer Patients with Combined Pulmonary Fibrosis and Emphysema.
Ueno F; Kitaguchi Y; Shiina T; Asaka S; Miura K; Yasuo M; Wada Y; Yoshizawa A; Hanaoka M
Respiration; 2017; 94(2):198-206. PubMed ID: 28637046
[TBL] [Abstract][Full Text] [Related]
16. [Risk factors and prognosis of lung cancer combined with pulmonary embolism].
Wang J; Zhou W; Xu L; Yang M; Meng L; Fan W; Pu X; Yang Y
Zhongguo Fei Ai Za Zhi; 2011 Oct; 14(10):780-4. PubMed ID: 22008107
[TBL] [Abstract][Full Text] [Related]
17. Analysis on risk factors of lung cancer complicated with pulmonary embolism.
Cui YQ; Tan XM; Liu B; Zheng Y; Zhang LY; Chen ZA; Wu XL
Clin Respir J; 2021 Jan; 15(1):65-73. PubMed ID: 32931143
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of pretreatment inflammatory biomarkers in advanced lung adenocarcinoma patients receiving first-line pemetrexed/platinum doublet.
Xiong Y; Zhao N; Zheng Y; Wang J; Wei F; Ren X
Tumour Biol; 2017 Jun; 39(6):1010428317701639. PubMed ID: 28618954
[TBL] [Abstract][Full Text] [Related]
19. [Clinical analysis of 23 lung cancer patients accompanied by pulmonary embolism].
Shao L; Wang ZH; Zuo JY
Ai Zheng; 2009 Apr; 28(4):416-9. PubMed ID: 19622304
[TBL] [Abstract][Full Text] [Related]
20. D-dimer and D-dimer/fibrinogen ratio in predicting pulmonary embolism in patients evaluated in a hospital emergency department.
Kara H; Bayir A; Degirmenci S; Kayis SA; Akinci M; Ak A; Celik B; Dogru A; Ozturk B
Acta Clin Belg; 2014 Aug; 69(4):240-5. PubMed ID: 25012747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
